Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
UBS
McKesson
QuintilesIMS
Merck
Cantor Fitzgerald
Accenture
Baxter
McKinsey

Generated: April 20, 2018

DrugPatentWatch Database Preview

RIVASTIGMINE TARTRATE Drug Profile

« Back to Dashboard

When do Rivastigmine Tartrate patents expire, and what generic alternatives are available?

Rivastigmine Tartrate is a drug marketed by Ajanta Pharma Ltd, Alembic Pharms Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Dr Reddys Labs Inc, Macleods Pharms Ltd, Orchid Hlthcare, Sun Pharm Inds Ltd, and Watson Labs. and is included in ten NDAs.

The generic ingredient in RIVASTIGMINE TARTRATE is rivastigmine tartrate. There are thirty-two drug master file entries for this compound. Twenty suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the rivastigmine tartrate profile page.
Summary for RIVASTIGMINE TARTRATE
US Patents:0
Applicants:10
NDAs:10
Suppliers / Packagers: 18
Bulk Api Vendors: 83
Clinical Trials: 219
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RIVASTIGMINE TARTRATE at DailyMed
Drug patent expirations by year for RIVASTIGMINE TARTRATE
Pharmacology for RIVASTIGMINE TARTRATE
Drug ClassCholinesterase Inhibitor
Mechanism of ActionCholinesterase Inhibitors

US Patents and Regulatory Information for RIVASTIGMINE TARTRATE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 090879-004 Jun 10, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Macleods Pharms Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 203148-004 Aug 22, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 077131-001 Oct 22, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Orchid Hlthcare RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 090879-001 Jun 10, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Accenture
Baxter
Dow
Federal Trade Commission
Fish and Richardson
AstraZeneca
US Army
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
DrugPatentWatch reviews  
Links

Follow DrugPatentWatch: